Preconditioning methods in the management of hepatic ischemia reperfusion- induced injury: Update on molecular and future perspectives

Hepatology Research

Volumn 47, Issue 1, 2017, Pages 31-48

  Suyavaran, Arumugam ^a   Thirunavukkarasu, Chinnasamy ^a  

^a PONDICHERRY UNIVERSITY   (India)

Author keywords

apoptosis; hepatic ischemia reperfusion; inflammation; necrosis; preconditioning

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; AMIFOSTINE; ASTAXANTHIN; CHLOROGENIC ACID; CRYPTOTANSHINONE; CURCUMIN; FERULIC ACID; GLUTATHIONE; HEME OXYGENASE 1; HYDROXYTYROSOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MANGAFODIPIR; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTOPORPHYRIN ZINC; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; ROSMARINIC ACID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; XANTHOHUMOL;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT PRECONDITIONING; BIOLOGICAL MODEL; COLD PERFUSED LIVER MODEL; CRYOPRESERVATION; DISEASE MODEL; DRUG MECHANISM; DRUG TARGETING; GENE SILENCING; GENE TARGETING; GENE TRANSFER; HEPATIC ISCHEMIA REPERFUSION INJURY; HUMAN; IMMUNOMODULATION; ISCHEMIC PRECONDITIONING; LIVER CIRRHOSIS; LIVER INJURY; LIVER PROTECTION; LIVER TRANSPLANTATION; MEDICAL RESEARCH; NONHUMAN; OXIDATIVE STRESS; PHARMACEUTICAL PRECONDITIONING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; UNCERTAINTY; WARM PERFUSED LIVER MODEL;

EID: 85008613593     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12706     Document Type: Review

References (135)

1. Papadopoulos D, Siempis T, Theodorakou E, Tsoulfas G. Hepatic ischemia and reperfusion injury and trauma: current concepts. Arch Trauma Res 2013; 2(2): 63–70.
2. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18(8): 891–902.
3. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32(2): 169–73.
4. Koti RS, Seifalian AM, McBride AG, Yang W, Davidson BR. The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. FASEB J 2002; 16(12): 1654–6.
5. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia–reperfusion injury. Am J Surg 2001; 181(2): 160–6.
6. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia–reperfusion injury: a review. Liver Transpl 2005; 11(9): 1031–47.
7. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125(3): 917–36.
8. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190(3): 255–66.
9. Yoon SY, Kim CY, Han HJ, Lee KO, Song TJ. Protective effect of ischemic post conditioning against hepatic ischemic reperfusion injury in rat liver. Ann Surg Treat Res 2015; 88(5): 241–5.
10. Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia–reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006; 290(6): G1083–8.
11. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226(6): 704–11 discussion 11-13.
12. Massip-Salcedo M, Rosello-Catafau J, Prieto J, Avila MA, Peralta C. The response of the hepatocyte to ischemia. Liver Int 2007; 27(1): 6–16.
13. Bahde R, Spiegel HU. Hepatic ischemia–reperfusion injury from bench to bedside. Br J Surg 2010; 97(10): 1461–75.
14. Kim YI. Ischemia–reperfusion injury of the human liver during hepatic resection. J Hepatobiliary Pancreat Surg 2003; 10(3): 195–9.
15. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53(5): 957–78.
16. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27(6): 1652–60.
17. Selzner N, Selzner M, Tian Y, Kadry Z, Clavien PA. Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: A TNF-α/IL-6-dependent mechanism. Hepatology 2002; 36(4): 812–8.
18. Gujral JS, Bucci TJ, Farhood A, Jaeschke H. Mechanism of cell death during warm hepatic ischemia–reperfusion in rats: apoptosis or necrosis? Hepatology 2001; 33(2): 397–405.
19. Kupiec-Weglinski JW, Busuttil RW. Ischemia and reperfusion injury in liver transplantation. Transplant Proc 2005; 37(4): 1653–6.
20. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 2011; 11(8): 1563–9.
21. Wanner GA, Ertel W, Muller P et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996; 5(1): 34–40.
22. Zhang W, Wang M, Xie HY et al. Role of reactive oxygen species in mediating hepatic ischemia–reperfusion injury and its therapeutic applications in liver transplantation. Transplant Proc 2007; 39(5): 1332–7.
23. Abe Y, Hines IN, Zibari G et al. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med 2009; 46(1): 1–7.
24. Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol 2013; 59: 1094–106.
25. Lang WG. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005; 79: 505–14.
26. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4: 499–511.
27. Baccala R, Gonzalez-Quintal R, Lawson BR et al. Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 2009; 5: 448–56.
28. Germani G, Theocharidou E, Adam R et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol 2012; 57(2): 288–96.
29. Jalan R, Gines P, Olson JC et al. Acute-on chronic liver failure. J Hepatol 2012; 57(6): 1336–48.
30. Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012; 57(1): 203–12.
31. Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW. Ischaemia-reperfusion injury in liver transplantation–from bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10(2): 79–89.
32. Casillas-Ramirez A, Mosbah IB, Franco-Gou R, Rimola A, Rosello-Catafau J, Peralta C. Ischemia–reperfusion syndrome associated with liver transplantation: an update. Gastroenterol Hepatol 2006; 29(5): 306–13.
33. Chu MJ, Vather R, Hickey AJ, Phillips AR, Bartlett AS. Impact of ischemic preconditioning on outcome in clinical liver surgery: a systematic review. Biomed Res Int 2015; 2015: 370451.
34. Han S, Sangwook Ko J, Jin SM et al. Glycemic responses to intermittent hepatic inflow occlusion in living liver donors. Liver Transpl 2014; 21(2): 180–6.
35. Quarrie R, Cramer BM, Lee DS et al. Ischemic preconditioning decreases mitochondrial proton leak and reactive oxygen species production in the postischemic heart. J Surg Res 2010; 165(1): 5–14.
36. Jaeschke H, Woolbright BL. Current strategies to minimize hepatic ischemia–reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando) 2012; 26(2): 103–14.
37. Figueira ER, Rocha-Filho JA, Nakatani M et al. Hepatic ischemic preconditioning increases portal vein flow in experimental liver ischemia reperfusion injury. Hepatobiliary Pancreat Dis Int 2014; 13(1): 40–7.
38. Richards JA, Wigmore SJ, Devey LR. Heme oxygenase system in hepatic ischemia–reperfusion injury. World J Gastroenterol 2010; 16(48): 6068–78.
39. Wang Y, Shen J, Xiong X et al. Remote ischemic preconditioning protects against liver ischemia–reperfusion injury via heme oxygenase-1-induced autophagy. PLoS One 2014; 9(6): e98834.
40. Guo JY, Yang T, Sun XG et al. Ischemic postconditioning attenuates liver warm ischemia–reperfusion injury through Akt-eNOS-NO-HIF pathway. J Biomed Sci 2011; 18: 79.
41. Liu A, Fang H, Wei W, Dirsch O, Dahmen U. Ischemic preconditioning protects against liver ischemia/reperfusion injury via heme oxygenase-1-mediated autophagy. Crit Care Med 2014; 42(12): e762–71.
42. Yan Y, Li G, Tian X et al. Ischemic preconditioning increases GSK-3beta/beta-catenin levels and ameliorates liver ischemia/reperfusion injury in rats. Int J Mol Med 2015; 35(6): 1625–32.
43. Shin HJ, Won NH, Lee HW. Remote ischemic preconditioning prevents lipopolysaccharide- induced liver injury through inhibition of NF-κB activation in mice. J Anesth 2014; 28(6): 898–905.
44. Hamada T, Duarte S, Tsuchihashi S, Busuttil RW, Coito AJ. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury. Am J Pathol 2009; 174: 2265–77.
45. Abu-Amara M, Yang SY, Seifalian A, Davidson B, Fuller B. The nitric oxide pathway–evidence and mechanisms for protection against liver ischemia reperfusion injury. Liver Int 2012; 32(4): 531–43.
46. Abu-Amara M, Yang SY, Quaglia A et al. Role of endothelial nitric oxide synthase in remote ischemic preconditioning of the mouse liver. Liver Transpl 2011; 17(5): 610–9.
47. Rolo AP, Teodoro JS, Peralta C, Rosello-Catafau J, Palmeira CM. Prevention of I/R injury in fatty livers by ischemic preconditioning is associated with increased mitochondrial tolerance: the key role of ATP synthase and mitochondrial permeability transition. Transpl Int 2009; 22(11): 1081–90.
48. Elias-Miro M, Jimenez-Castro MB, Mendes-Braz M, Casillas-Ramirez A, Peralta C. The current knowledge of the role of PPAR in hepatic ischemia–reperfusion injury. PPAR Res 2012; 802384.
49. Leal AJ, Tannuri AC, Belon AR et al. Effects of ischemic preconditioning in a pig model of large-for-size liver transplantation. Clinics (Sao Paulo) 2015; 70(2): 126–35.
50. Jimenez-Castro MB, Merono N, Mendes-Braz M et al. The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning. J Hepatol 2014; 62(1): 83–91.
51. Guimaraes Filho MA, Cortez E, Garcia-Souza EP et al. Effect of remote ischemic preconditioning in the expression of IL-6 and IL-10 in a rat model of liver ischemia–reperfusion injury. Acta Cir Bras 2015; 30(7): 452–60.
52. Eipel C, Glanemann M, Nuessler AK, Menger MD, Neuhaus P, Vollmar B. Ischemic preconditioning impairs liver regeneration in extended reduced-size livers. Ann Surg 2005; 241(3): 477–84.
53. Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Ischemic preconditioning for liver transplantation. Cochrane Database Syst Rev 2008; 1: CD006315.
54. Raza A, Dikdan G, Desai KK et al. Global gene expression profiles of ischemic preconditioning in deceased donor liver transplantation. Liver Transpl 2010; 16(5): 588–99.
55. Ye B, Zhao H, Hou H et al. Ischemic preconditioning provides no additive clinical value in liver resection of cirrhotic and non-cirrhotic patients under portal triad clamping: a prospective randomized controlled trial. Clin Res Hepatol Gastroenterol 2014; 38(4): 467–74.
56. Kapoor S, Berishvili E, Bandi S, Gupta S. Ischemic preconditioning affects long-term cell fate through DNA damage-related molecular signaling and altered proliferation. Am J Pathol 2014; 184(10): 2779–90.
57. O'Neill S, Leuschner S, McNally SJ, Garden OJ, Wigmore SJ, Harrison EM. Meta-analysis of ischemic preconditioning for liver resections. Br J Surg 2013; 100(13): 1689–700.
58. van Golen RF, Reiniers MJ, Olthof PB, van Gulik TM, Heger M. Sterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics. J Gastroenterol Hepatol 2012; 28(3): 394–400.
59. Guan LY, Fu PY, Li PD et al. Mechanisms of hepatic ischemia–reperfusion injury and protective effects of nitric oxide. World J Gastrointest Surg 2014; 6(7): 122–8.
60. Hines IN, Grisham MB. Divergent roles of superoxide and nitric oxide in liver ischemia and reperfusion injury. J Clin Biochem Nutr 2011; 48(1): 50–6.
61. Spencer NY, Zhou W, Li Q et al. Hepatocytes produce TNF-α following hypoxia-reoxygenation and liver ischemia–reperfusion in a NADPH oxidase- and c-Src-dependent manner. Am J Physiol Gastrointest Liver Physiol 2013; 305(1): G84–94.
62. van Golen RF, van Gulik TM, Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 2012; 52(8): 1382–402.
63. Reiniers MJ, van Golen RF, van Gulik TM, Heger M. Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia–reperfusion injury in the fatty liver. Antioxid Redox Signal 2013; 21(7): 1119–42.
64. Elias-Miro M, Jimenez-Castro MB, Rodes J, Peralta C. Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res 2013; 47(8): 555–68.
65. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003; 304: 463–70.
66. Massip-Salcedo M, Rosello-Catafau J, Prieto J, Avila MA, Peralta C. The response of the hepatocyte to ischemia. Liver Int 2007; 27: 6–16.
67. Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol 2013; 3: 977–1010.
68. Dunning S, Ur Rehman A, Tiebosch MH et al. Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death. Biochim Biophys Acta 2013; 1832(12): 2027–34.
69. Videla LA. Cytoprotective and suicidal signaling in oxidative stress. Biol Res 2011; 43(3): 363–9.
70. Evans ZP, Mandavilli BS, Ellett JD et al. Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion. Transplant Proc 2009; 41(10): 4094–8.
71. Rao J, Zhang C, Wang P, Lu L, Zhang F. All-trans retinoic acid alleviates hepatic ischemia/reperfusion injury by enhancing manganese superoxide dismutase in rats. Biol Pharm Bull 2010; 33(5): 869–75.
72. Suyavaran A, Ramamurthy C, Mareeswaran R, Subastri A, Lokeswara Rao P, Thirunavukkarasu C. TNF-α suppression by glutathione preconditioning attenuates hepatic ischemia reperfusion injury in young and aged rats. Inflamm Res 2014; 64(1): 71–81.
73. Kang JW, Koh EJ, Lee SM. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J Pineal Res 2011; 50(4): 403–11.
74. Kang JW, Lee SM. Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. J Pineal Res 2012; 53(1): 67–76.
75. Kireev R, Bitoun S, Cuesta S et al. Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis. Eur J Pharmacol 2012; 701(1–3): 185–93.
76. Curek GD, Cort A, Yucel G et al. Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion. Toxicology 2009; 267(1–3): 147–53.
77. Li J, Wang F, Xia Y et al. Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice. Mar Drugs 2015; 13(6): 3368–87.
78. Sun PP, Yuan F, Xu J, Sai K, Chen J, Guan S. Cryptotanshinone ameliorates hepatic normothermic ischemia and reperfusion injury in rats by anti-mitochondrial apoptosis. Biol Pharm Bull 2014; 37(11): 1758–65.
79. Lin CM, Lee JF, Chiang LL, Chen CF, Wang D, Su CL. The protective effect of curcumin on ischemia–reperfusion-induced liver injury. Transplant Proc 2012; 44(4): 974–7.
80. Inokuma T, Yamanouchi K, Tomonaga T et al. Curcumin improves the survival rate after a massive hepatectomy in rats. Hepatogastroenterology 2013; 59(119): 2243–7.
81. Yun N, Kang JW, Lee SM. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. J Nutr Biochem 2012; 23(10): 1249–55.
82. Liu A, Huang L, Fan H et al. Baicalein pretreatment protects against liver ischemia/reperfusion injury via inhibition of NF-κB pathway in mice. Int Immunopharmacol 2014; 24(1): 72–9.
83. Ramalho LN, Pasta AA, Terra VA et al. Rosmarinic acid attenuates hepatic ischemia and reperfusion injury in rats. Food Chem Toxicol 2014; 74: 270–8.
84. Kim HY, Lee SM. Ferulic acid attenuates ischemia/reperfusion-induced hepatocyte apoptosis via inhibition of JNK activation. Eur J Pharm Sci 2012; 45(5): 708–15.
85. Jiang K, Wang X, Mao X et al. Ambroxol alleviates hepatic ischemia reperfusion injury by antioxidant and antiapoptotic pathways. Transplant Proc 2013; 45(6): 2439–45.
86. Pan S, Liu L, Pan H et al. Protective effects of hydroxytyrosol on liver ischemia/reperfusion injury in mice. Mol Nutr Food Res 2013; 57(7): 1218–27.
87. Xu Z, Wang Y. Huperzine A attenuates hepatic ischemia reperfusion injury via anti-oxidative and anti-apoptotic pathways. Mol Med Rep 2014; 10(2): 701–6.
88. Somi MH, Hajipour B, Asl NA et al. Pioglitazone attenuates ischemia/reperfusion-induced liver injury in rats. Transplant Proc 2009; 41(10): 4105–9.
89. Hataji K, Watanabe T, Oowada S et al. Effects of a calcium-channel blocker (CV159) on hepatic ischemia/reperfusion injury in rats: evaluation with selective NO/pO2 electrodes and an electron paramagnetic resonance spin-trapping method. Biol Pharm Bull 2010; 33(1): 77–83.
90. McDonald KA, Huang H, Tohme S et al. Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling. Mol Med 2014; 20: 639–48.
91. Lee LY, Kaizu T, Toyokawa H et al. Carbon monoxide induces hypothermia tolerance in Kupffer cells and attenuates liver ischemia/reperfusion injury in rats. Liver Transpl 2011; 17(12): 1457–66.
92. Russo L, Gracia-Sancho J, Garcia-Caldero H et al. Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers. Hepatology 2011; 55(3): 921–30.
93. Kuriyama N, Isaji S, Hamada T et al. The cytoprotective effects of addition of activated protein C into preservation solution on small-for-size grafts in rats. Liver Transpl 2010; 16(1): 1–11.
94. Matsuda A, Kuriyama N, Kato H et al. Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia–Reperfusion Injury. Biomed Res Int 2015; 2015:635041.
95. Tanemura A, Kuriyama N, Azumi Y et al. Thrombomodulin administration attenuates ischemia–reperfusion injury of the remnant liver after 70 % hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation. Transplant Proc 2014; 46: 1107–11.
96. Zaki HF, Abdelsalam RM. Vinpocetine protects liver against ischemia–reperfusion injury. Can J Physiol Pharmacol 2013; 91(12): 1064–70.
97. Grossini E, Pollesello P, Bellofatto K et al. Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats. Liver Transpl 2013; 20(3): 361–75.
98. Song S, Liu W, Liu F et al. Magnesium lithospermate B reduces inflammatory response in a mouse model of hepatic ischemia–reperfusion injury. Cell Biochem Biophys 2014; 69(2): 347–55.
99. Demiryilmaz I, Turan MI, Kisaoglu A, Gulapoglu M, Yilmaz I, Suleyman H. Protective effect of nimesulide against hepatic ischemia/reperfusion injury in rats: effects on oxidant/antioxidants, DNA mutation and COX-1/COX-2 levels. Pharmacol Rep 2014; 66(4): 647–52.
100. Kunak CS, Kukula O, Mutlu E et al. The effect of etoricoxib on hepatic ischemia–reperfusion injury in rats. Oxid Med Cell Longev 2015; 2015: 598162.
101. Tao X, Sun X, Yin L et al. Dioscin ameliorates cerebral ischemia/reperfusion injury through the down regulation of TLR4 signaling via HMGB-1 inhibition. Free Radic Biol Med 2015; 84: 103–15.
102. Bejaoui M, Pantazi E, De Luca V et al. Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury. J Pharmacol Exp Ther 2015; 355(2): 191–8.
103. Li Y, Li T, Qi H, Yuan F. Minocycline protects against hepatic ischemia/reperfusion injury in a rat model. Biomed Rep 2015; 3(1): 19–24.
104. Kuroda T, Miyake H, Naruse T, Ohnishi T, Izumi K, Tashiro S. The protective effect of selenoprotein P on injury in rat liver transplantation. Hepatogastroenterology 2009; 56(94–95): 1501–6.
105. Wang J, Deng X, Yi S et al. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia and reperfusion injury in mice. Shock 2014; 43(4): 379–86.
106. Ren F, Duan Z, Cheng Q et al. Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism. Hepatology 2011; 54(2): 687–96.
107. Chi X, Zhang R, Shen N et al. Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway. Hepatol Int 2015; 9(2): 321–9.
108. Li JQ, Qi HZ, He ZJ et al. Cytoprotective effects of human interleukin-10 gene transfer against necrosis and apoptosis induced by hepatic cold ischemia/reperfusion injury. J Surg Res 2009; 157(1): e71–8.
109. Si ZZ, Li JQ, Qi HZ, He ZJ, Hu W, Li YN. Recombinant adenovirus vector Ad-hIL-10 protects grafts from cold ischemia–reperfusion injury following orthotopic liver transplantation in rats. Hepatobiliary Pancreat Dis Int 2010; 9(2): 144–8.
110. Shi J, Shao W, Yang D et al. Hydrodynamics-based transfection of plasmid encoding receptor activator for NFκB-Fc protects against hepatic ischemia/reperfusion injury in mice. Liver Transpl 2010; 16(5): 611–20.
111. Un K, Kawakami S, Yoshida M et al. Efficient suppression of murine intracellular adhesion molecule-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation. Hepatology 2012; 56(1): 259–69.
112. Jiang N, Zhang X, Zheng X et al. Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury. Am J Transplant 2011; 11(9): 1835–44.
113. Meimei H, Dejin M, Erzhen C et al. Inhibiting the toll-like receptor 4 Toll/interleukin-1 receptor domain protects against hepatic warm ischemia and reperfusion injury in mice. Crit Care Med 2013; 42(2): e123–31.
114. Hernandez-Alejandro R, Zhang X, Croome KP et al. Reduction of liver ischemia reperfusion injury by silencing of TNF-α gene with shRNA. J Surg Res 2012; 176(2): 614–20.
115. Li L, Li G, Yu C et al. A role of microRNA-370 in hepatic ischemia–reperfusion injury by targeting transforming growth factor-beta receptor II. Liver Int 2013; 35(4): 1124–32.
116. Van Wijk SJ, Hageman GJ. Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radic Biol Med 2005; 39(1): 81–90.
117. Cursio R, Colosetti P, Auberger P, Gugenheim J. Liver apoptosis following normothermic ischemia–reperfusion: in vivo evaluation of caspase activity by FLIVO assay in rats. Transplant Proc 2008; 40(6): 2038–41.
118. Cursio R, Miele C, Filippa N, Van Obberghen E, Gugenheim J. Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia–reperfusion in rats. Transplant Proc 2008; 40(6): 2042–5.
119. Kato H, Duarte S, Liu D, Busuttil RW, Coito AJ. Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice. PLoS One 2015; 10: e0137642.
120. Kim SJ, Eum HA, Billiar TR, Lee SM. Role of heme oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats. Shock 2013; 39(4): 380–8.
121. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-α-induced apoptosis in liver injury. J Cell Mol Med 2004; 8(4): 445–54.
122. Shuh M, Bohorquez H, Loss GE Jr, Cohen AJ. Tumor Necrosis Factor-α: Life and death of hepatocytes during liver ischemia/reperfusion injury. Ochsner J 2013; 13(1): 119–30.
123. Kim JS, He L, Qian T, Lemasters JJ. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr Mol Med 2003; 3(6): 527–35.
124. Weigand K, Brost S, Steinebrunner N, Buchler M, Schemmer P, Muller M. Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg 2012; 2012: 176723.
125. Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol 2013; 3(2): 977–1010.
126. Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia–reperfusion injury. Am J Transplant 2013; 13(11): 2797–804.
127. Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature 2015; 517(7534): 311–20.
128. Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin North Am 2010; 90(4): 665–77.
129. Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol 2013; 59(3): 583–94.
130. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371(9615): 838–51.
131. Haddad L, Cassenote AJ, Andraus W et al. Factors associated with mortality and graft failure in liver transplants: A Hierarchical approach. PLoS One 2015; 10(8): e0134874.
132. Graham JA, Guarrera JV. "Resuscitation" of marginal liver allografts for transplantation with machine perfusion technology. J Hepatol 2014; 61(2): 418–31.
133. Saidi RF. Utilization of expanded criteria donors in liver transplantation. Int J Organ Transplant Med 2013; 4(2): 46–59.
134. Routh D, Naidu S, Sharma S, Ranjan P, Godara R. Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. J Clin Exp Hepatol 2013; 3: 337–46.
135. Habka D, Mann D, Landes R, Soto-Gutierrez A. Future economics of liver transplantation: A 20-year cost modeling forecast and the prospect of bioengineering autologous liver grafts. PLoS One 2015; 10(7): e0131764.